CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 211 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 2.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $308,000 | -7.2% | 26,196 | +5.3% | 0.01% | -25.0% |
Q4 2018 | $332,000 | -2.1% | 24,875 | +2.8% | 0.02% | +14.3% |
Q3 2018 | $339,000 | -3.4% | 24,198 | +8.4% | 0.01% | -17.6% |
Q2 2018 | $351,000 | +4.8% | 22,324 | +9.6% | 0.02% | +88.9% |
Q1 2018 | $335,000 | -4.8% | 20,371 | +4.6% | 0.01% | +28.6% |
Q4 2017 | $352,000 | – | 19,470 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 8,340,193 | $227,229 | 10.94% |
Novo Holdings A/S | 3,377,768 | $92,044,178 | 6.80% |
Parallel Advisors, LLC | 3,723,483 | $101,446,294 | 3.38% |
TANAKA CAPITAL MANAGEMENT INC | 37,569 | $1,024 | 2.92% |
S&T BANK/PA | 334,252 | $9,107 | 1.76% |
Birchview Capital, LP | 50,000 | $1,362,250 | 1.16% |
Granite Investment Partners, LLC | 798,552 | $21,756,549 | 0.91% |
FAS Wealth Partners, Inc. | 310,764 | $8,466,766 | 0.90% |
Clearview Wealth Advisors LLC | 25,258 | $688,155 | 0.85% |
Bridge City Capital, LLC | 43,485 | $1,184,749 | 0.60% |